MYL1 and amyotrophic lateral sclerosis: MYL1, the non-regulatory myosin light chain protein that builds skeletal muscles, is likely regulated in response to muscle atrophy and wasting in ALS patients (Ravenscroft et al, 2018; Rayment et al, 1993; Reggiani et al, 2000).